Scheme 1: A preclinical pipeline for the development of novel migrastatic drugs.
From: A preclinical pipeline to evaluate migrastatics as therapeutic agents in metastatic melanoma
Schematic representation of the main workflow steps performed in this study (numbered to depict the order; for details see text).
